APAC Travel Vaccine Market - Industry Trends and Forecast to 2032

Description

List of Tables

Asia-Pacific travel vaccine market is expected to reach USD 2,650,063.06 thousand by 2032 from USD 1,292,116.60 thousand in 2023, growing at a substantial CAGR of 8.5% in the forecast period of 2024 to 2032.

Market Segmentation:

Asia-Pacific travel vaccines market, By Composition (Combination Vaccines and Mono Vaccines), Type (Inactivated Vaccines, Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, Live-Attenuated Vaccines, Toxoid Vaccines, DNA Vaccines, and Viral Vector Vaccines), Category (Recommended Vaccine, Routine Vaccine and Required Vaccine), Disease (Typhoid, Hepatitis, Cholera, Varicella, Influenza, Japanese Encephalitis, Meningococcal Meningitis, Yellow Fever, Rabies, DPT, Measles and Mumps, Tick-Borne Encephalitis, Malaria, Covid-19, Polio and Others), Route of Administration (Injectable and Oral), Gender (Male and Female), Patient Type (Adult, Pediatric and Geriatric), Age Group (20-50 Years, Less than 20 Years and Above 50 Years), Distribution Channel (B2B and B2C), Countries (China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Malaysia, Philippines, Vietnam, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2032

Some of the major factors contributing to the growth of the Asia-Pacific travel vaccines market are:

Driver
Rising incidence of infectious diseases
Restraint
High cost of travel vaccines
Opportunity
Advancements in vaccine technology

Market Players

Some major companies dealing in the Asia-Pacific travel vaccines market are:

GSK plc.
Bavarian Nordic
Pfizer Inc.
Abbott
CSL
AstraZeneca
Sanofi
Merck & Co., Inc.
Johnson & Johnson Services Inc.
Dynavax Technologies.

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC TRAVEL VACCINES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 PIPELINE ANALYSIS

5 MARKET OVERVIEW

5.1 DRIVERS
- 5.1.1 RISING INCIDENCE OF INFECTIOUS DISEASES
- 5.1.2 INCREASING TRAVEL AND TOURISM
- 5.1.3 GOVERNMENT REGULATIONS AND RECOMMENDATIONS REGARDING VACCINATION
- 5.1.4 EXPANSION OF TRAVEL MEDICINE CLINICS
5.2 RESTRAINTS
- 5.2.1 HIGH COST OF TRAVEL VACCINES
- 5.2.2 REGULATORY HURDLES FOR APPROVAL
5.3 OPPORTUNITIES
- 5.3.1 ADVANCEMENTS IN VACCINE TECHNOLOGY
- 5.3.2 GROWING AWARENESS REGARDING VACCINES
- 5.3.3 INTEGRATION OF DIGITAL HEALTH SOLUTIONS
5.4 CHALLENGES
- 5.4.1 COLD CHAIN REQUIREMENTS FOR STORAGE
- 5.4.2 VACCINE HESITANCY AND MISINFORMATION

6 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY COMPOSITION

6.1 OVERVIEW
6.2 COMBINATION VACCINES
6.3 MONO VACCINES

7 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY TYPE

7.1 OVERVIEW
7.2 INACTIVATED VACCINES
- 7.2.1 HEPATITIS A
- 7.2.2 INFLUENZA
- 7.2.3 RABIES
- 7.2.4 TICK-BORNE ENCEPHALITIS
- 7.2.5 JAPANESE ENCEPHALITIS
- 7.2.6 POLIO
7.3 SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES
- 7.3.1 HEPATITIS B
- 7.3.2 MENINGOCOCCAL
- 7.3.3 MALARIA
- 7.3.4 COVID-19
7.4 LIVE-ATTENUATED VACCINES
- 7.4.1 TYPHOID
- 7.4.2 CHOLERA
- 7.4.3 YELLOW FEVER
- 7.4.4 MEASLES
- 7.4.5 MUMPS
- 7.4.6 RUBELLA
- 7.4.7 VARICELLA
- 7.4.8 OTHERS
7.5 TOXOID VACCINES
- 7.5.1 DIPHTHERIA
- 7.5.2 TETANUS
7.6 DNA VACCINES
7.7 VIRAL VECTOR VACCINES

8 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY CATEGORY

8.1 OVERVIEW
8.2 RECOMMENDED VACCINE
- 8.2.1 TYPHOID FEVER VACCINES
- 8.2.2 HEPATITIS A
- 8.2.3 CHOLERA
- 8.2.4 RABIES
- 8.2.5 TICK-BORNE ENCEPHALITIS
- 8.2.6 JAPANESE ENCEPHALITIS
- 8.2.7 MALARIA
- 8.2.8 OTHERS
8.3 ROUTINE VACCINE
- 8.3.1 HEPATITIS B
- 8.3.2 INFLUENZA VACCINES
- 8.3.3 PNEUMOCOCCAL
- 8.3.4 DIPHTHERIA
- 8.3.5 TETANUS
- 8.3.6 MEASLES
- 8.3.7 MUMPS
- 8.3.8 RUBELLA
- 8.3.9 PERTUSSIS
- 8.3.10 OTHERS
8.4 REQUIRED VACCINE
- 8.4.1 YELLOW FEVER
- 8.4.2 MENINGOCOCCAL
- 8.4.3 POLIO VACCINES

9 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY DISEASE

9.1 OVERVIEW
9.2 TYPHOID
9.3 HEPATITIS
- 9.3.1 HEPATITIS A
- 9.3.2 HEPATITIS B
9.4 CHOLERA
9.5 VARICELLA
9.6 INFLUENZA
9.7 JAPANESE ENCEPHALITIS
9.8 MENINGOCOCCAL MENINGITIS
9.9 YELLOW FEVER
9.10 RABIES
9.11 DPT
9.12 MEASLES AND MUMPS
9.13 TICK-BORNE ENCEPHALITIS
9.14 MALARIA
9.15 COVID-19
9.16 POLIO
9.17 OTHERS

10 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION

10.1 OVERVIEW
10.2 INJECTABLE
- 10.2.1 INTRAMUSCULAR
- 10.2.2 SUBCUTANEOUS
- 10.2.3 OTHERS
10.3 ORAL

11 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY GENDER

11.1 OVERVIEW
11.2 MALE
11.3 FEMALE

12 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY PATIENT TYPE

12.1 OVERVIEW
12.2 ADULT
12.3 PEDIATRIC
12.4 GERIATRIC

13 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY AGE GROUP

13.1 OVERVIEW
13.2 20-50 YEARS
13.3 LESS THAN 20 YEARS
13.4 ABOVE 50 YEARS

14 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW
14.2 B2B
14.3 B2C

15 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY REGION

15.1 ASIA-PACIFIC
- 15.1.1 INDIA
- 15.1.2 CHINA
- 15.1.3 MALAYSIA
- 15.1.4 SOUTH KOREA
- 15.1.5 JAPAN
- 15.1.6 AUSTRALIA
- 15.1.7 THAILAND
- 15.1.8 VIETNAM
- 15.1.9 SINGAPORE
- 15.1.10 INDONESIA
- 15.1.11 PHILIPPINES
- 15.1.12 REST OF ASIA-PACIFIC

16 ASIA-PACIFIC TRAVEL VACCINE MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 PFIZER INC.
- 18.1.1 COMPANY SNAPSHOT
- 18.1.2 REVENUE ANALYSIS
- 18.1.3 COMPANY SHARE ANALYSIS
- 18.1.4 PRODUCT PORTFOLIO
- 18.1.5 RECENT DEVELOPMENT
18.2 SANOFI
- 18.2.1 COMPANY SNAPSHOT
- 18.2.2 REVENUE ANALYSIS
- 18.2.3 COMPANY SHARE ANALYSIS
- 18.2.4 PRODUCT PORTFOLIO
- 18.2.5 RECENT DEVELOPMENT
18.3 JOHNSON & JOHNSON SERVICES INC.
- 18.3.1 COMPANY SNAPSHOT
- 18.3.2 REVENUE ANALYSIS
- 18.3.3 COMPANY SHARE ANALYSIS
- 18.3.4 PRODUCT PORTFOLIO
- 18.3.5 RECENT DEVELOPMENTS
18.4 GSK PLC.
- 18.4.1 COMPANY SNAPSHOT
- 18.4.2 REVENUE ANALYSIS
- 18.4.3 COMPANY SHARE ANALYSIS
- 18.4.4 PRODUCT PORTFOLIO
- 18.4.5 RECENT DEVELOPMENT
18.5 MERCK & CO., INC.
- 18.5.1 COMPANY SNAPSHOT
- 18.5.2 REVENUE ANALYSIS
- 18.5.3 COMPANY SHARE ANALYSIS
- 18.5.4 PRODUCT PORTFOLIO
- 18.5.5 RECENT DEVELOPMENT
18.6 ABBOTT
- 18.6.1 COMPANY SNAPSHOT
- 18.6.2 REVENUE ANALYSIS
- 18.6.3 PRODUCT PORTFOLIO
- 18.6.4 RECENT DEVELOPMENT
18.7 ASTRAZENECA
- 18.7.1 COMPANY SNAPSHOT
- 18.7.2 REVENUE ANALYSIS
- 18.7.3 PRODUCT PORTFOLIO
- 18.7.4 RECENT DEVELOPMENT
18.8 BAVARIAN NORDIC
- 18.8.1 COMPANY SNAPSHOT
- 18.8.2 REVENUE ANALYSIS
- 18.8.3 PRODUCT PORTFOLIO
- 18.8.4 RECENT DEVELOPMENT
18.9 CSL
- 18.9.1 COMPANY SNAPSHOT
- 18.9.2 REVENUE ANALYSIS
- 18.9.3 PRODUCT PORTFOLIO
- 18.9.4 RECENT DEVELOPMENT
18.10 DYNAVAX TECHNOLOGIES.
- 18.10.1 COMPANY SNAPSHOT
- 18.10.2 REVENUE ANALYSIS
- 18.10.3 PRODUCT PORTFOLIO
- 18.10.4 RECENT DEVELOPMENTS
18.11 VALNEVA SE
- 18.11.1 COMPANY SNAPSHOT
- 18.11.2 REVENUE ANALYSIS
- 18.11.3 PRODUCT PORTFOLIO
- 18.11.4 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF TABLES

TABLE 1 PIPELINE ANALYSIS OF TRAVEL VACCINES MARKET
TABLE 2 VACCINES RECOMMENDATION FOR INTERNATIONAL TRAVELERS
TABLE 3 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC COMBINATION VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC MONO VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC DNA VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC VIRAL VECTOR VACCINES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC RECOMMENDED VACCINES IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC ROUTINE VACCINES IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC REQUIRED VACCINES IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC TYPHOID IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC HEPATITIS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC CHOLERA IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC VARICELLA IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC INFLUENZA IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC JAPANESE ENCEPHALITIS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC MENINGOCOCCAL MENINGITIS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC YELLOW FEVER IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC RABIES IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC DPT IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC MEASLES AND MUMPS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC TICK-BORNE ENCEPHALITIS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC MALARIA IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC COVID-19 IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC POLIO IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC OTHERS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC INJECTABLE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC ORAL IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC MALE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC FEMALE IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC ADULT IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC PEDIATRIC IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 52 ASIA-PACIFIC GERIATRIC IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 53 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 54 ASIA-PACIFIC 20-50 YEARS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 55 ASIA-PACIFIC LESS THAN 20 YEARS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 56 ASIA-PACIFIC ABOVE 50 YEARS IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 57 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 58 ASIA-PACIFIC B2B IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 59 ASIA-PACIFIC B2C IN TRAVEL VACCINE MARKET, BY REGION, 2022-2032 (USD THOUSAND)
TABLE 60 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY COUNTRY, 2022-2032 (USD THOUSAND)
TABLE 61 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 62 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 63 ASIA-PACIFIC INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 64 ASIA-PACIFIC SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 65 ASIA-PACIFIC LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 66 ASIA-PACIFIC TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 67 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 68 ASIA-PACIFIC RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 69 ASIA-PACIFIC ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 70 ASIA-PACIFIC REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 71 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 72 ASIA-PACIFIC HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 73 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 74 ASIA-PACIFIC INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 75 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 76 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 77 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 78 ASIA-PACIFIC TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 79 INDIA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 80 INDIA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 81 INDIA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 82 INDIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 83 INDIA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 84 INDIA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 85 INDIA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 86 INDIA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 87 INDIA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 88 INDIA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 89 INDIA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 90 INDIA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 91 INDIA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 92 INDIA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 93 INDIA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 94 INDIA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 95 INDIA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 96 INDIA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 97 CHINA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 98 CHINA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 99 CHINA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 100 CHINA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 101 CHINA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 102 CHINA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 103 CHINA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 104 CHINA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 105 CHINA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 106 CHINA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 107 CHINA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 108 CHINA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 109 CHINA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 110 CHINA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 111 CHINA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 112 CHINA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 113 CHINA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 114 CHINA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 115 MALAYSIA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 116 MALAYSIA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 117 MALAYSIA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 118 MALAYSIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 119 MALAYSIA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 120 MALAYSIA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 121 MALAYSIA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 122 MALAYSIA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 123 MALAYSIA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 124 MALAYSIA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 125 MALAYSIA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 126 MALAYSIA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 127 MALAYSIA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 128 MALAYSIA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 129 MALAYSIA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 130 MALAYSIA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 131 MALAYSIA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 132 MALAYSIA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 133 SOUTH KOREA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 134 SOUTH KOREA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 135 SOUTH KOREA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 136 SOUTH KOREA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 137 SOUTH KOREA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 138 SOUTH KOREA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 139 SOUTH KOREA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 140 SOUTH KOREA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 141 SOUTH KOREA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 142 SOUTH KOREA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 143 SOUTH KOREA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 144 SOUTH KOREA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 145 SOUTH KOREA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 146 SOUTH KOREA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 147 SOUTH KOREA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 148 SOUTH KOREA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 149 SOUTH KOREA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 150 SOUTH KOREA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 151 JAPAN TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 152 JAPAN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 153 JAPAN INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 154 JAPAN SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 155 JAPAN LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 156 JAPAN TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 157 JAPAN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 158 JAPAN RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 159 JAPAN ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 160 JAPAN REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 161 JAPAN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 162 JAPAN HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 163 JAPAN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 164 JAPAN INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 165 JAPAN TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 166 JAPAN TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 167 JAPAN TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 168 JAPAN TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 169 AUSTRALIA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 170 AUSTRALIA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 171 AUSTRALIA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 172 AUSTRALIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 173 AUSTRALIA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 174 AUSTRALIA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 175 AUSTRALIA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 176 AUSTRALIA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 177 AUSTRALIA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 178 AUSTRALIA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 179 AUSTRALIA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 180 AUSTRALIA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 181 AUSTRALIA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 182 AUSTRALIA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 183 AUSTRALIA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 184 AUSTRALIA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 185 AUSTRALIA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 186 AUSTRALIA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 187 THAILAND TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 188 THAILAND TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 189 THAILAND INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 190 THAILAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 191 THAILAND LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 192 THAILAND TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 193 THAILAND TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 194 THAILAND RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 195 THAILAND ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 196 THAILAND REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 197 THAILAND TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 198 THAILAND HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 199 THAILAND TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 200 THAILAND INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 201 THAILAND TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 202 THAILAND TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 203 THAILAND TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 204 THAILAND TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 205 VIETNAM TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 206 VIETNAM TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 207 VIETNAM INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 208 VIETNAM SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 209 VIETNAM LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 210 VIETNAM TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 211 VIETNAM TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 212 VIETNAM RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 213 VIETNAM ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 214 VIETNAM REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 215 VIETNAM TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 216 VIETNAM HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 217 VIETNAM TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 218 VIETNAM INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 219 VIETNAM TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 220 VIETNAM TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 221 VIETNAM TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 222 VIETNAM TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 223 SINGAPORE TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 224 SINGAPORE TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 225 SINGAPORE INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 226 SINGAPORE SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 227 SINGAPORE LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 228 SINGAPORE TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 229 SINGAPORE TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 230 SINGAPORE RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 231 SINGAPORE ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 232 SINGAPORE REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 233 SINGAPORE TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 234 SINGAPORE HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 235 SINGAPORE TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)

TABLE 236 SINGAPORE INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 237 SINGAPORE TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 238 SINGAPORE TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 239 SINGAPORE TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 240 SINGAPORE TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 241 INDONESIA TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 242 INDONESIA TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 243 INDONESIA INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 244 INDONESIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 245 INDONESIA LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 246 INDONESIA TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 247 INDONESIA TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 248 INDONESIA RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 249 INDONESIA ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 250 INDONESIA REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 251 INDONESIA TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 252 INDONESIA HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 253 INDONESIA TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 254 INDONESIA INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 255 INDONESIA TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 256 INDONESIA TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 257 INDONESIA TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 258 INDONESIA TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 259 PHILIPPINES TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)
TABLE 260 PHILIPPINES TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 261 PHILIPPINES INACTIVATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 262 PHILIPPINES SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 263 PHILIPPINES LIVE-ATTENUATED VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 264 PHILIPPINES TOXOID VACCINES IN TRAVEL VACCINE MARKET, BY TYPE, 2022-2032 (USD THOUSAND)
TABLE 265 PHILIPPINES TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 266 PHILIPPINES RECOMMENDED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 267 PHILIPPINES ROUTINE VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 268 PHILIPPINES REQUIRED VACCINE IN TRAVEL VACCINE MARKET, BY CATEGORY, 2022-2032 (USD THOUSAND)
TABLE 269 PHILIPPINES TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 270 PHILIPPINES HEPATITIS IN TRAVEL VACCINE MARKET, BY DISEASE, 2022-2032 (USD THOUSAND)
TABLE 271 PHILIPPINES TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 272 PHILIPPINES INJECTABLE IN TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 (USD THOUSAND)
TABLE 273 PHILIPPINES TRAVEL VACCINE MARKET, BY GENDER, 2022-2032 (USD THOUSAND)
TABLE 274 PHILIPPINES TRAVEL VACCINE MARKET, BY PATIENT TYPE, 2022-2032 (USD THOUSAND)
TABLE 275 PHILIPPINES TRAVEL VACCINE MARKET, BY AGE GROUP, 2022-2032 (USD THOUSAND)
TABLE 276 PHILIPPINES TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 (USD THOUSAND)
TABLE 277 REST OF ASIA-PACIFIC TRAVEL VACCINE MARKET, BY COMPOSITION, 2022-2032 (USD THOUSAND)

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC TRAVEL VACCINES MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC TRAVEL VACCINES MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC TRAVEL VACCINES MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC TRAVEL VACCINES MARKET : ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC TRAVEL VACCINES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC TRAVEL VACCINES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC TRAVEL VACCINES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC TRAVEL VACCINES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA-PACIFIC TRAVEL VACCINES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC TRAVEL VACCINES MARKET: SEGMENTATION
FIGURE 11 RISING AWARENESS ABOUT THE IMPORTANCE OF VACCINATION AMONG TRAVELERS ARE EXPECTED TO DRIVE THE ASIA-PACIFIC TRAVEL VACCINES MARKET IN THE FORECAST PERIOD OF 2024 TO 2032
FIGURE 12 COMBINATION VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC TRAVEL VACCINES MARKET IN 2021 & 2032
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC TRAVEL VACCINE MARKET
FIGURE 14 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY COMPOSITION, 2023
FIGURE 15 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY COMPOSITION, 2024-2032 (USD THOUSAND)
FIGURE 16 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY COMPOSITION , CAGR (2024-2032)
FIGURE 17 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY COMPOSITION, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY TYPE, 2023
FIGURE 19 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY TYPE, 2024-2032 (USD THOUSAND)
FIGURE 20 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY TYPE, CAGR (2024-2032)
FIGURE 21 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY CATEGORY, 2023
FIGURE 23 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY CATEGORY, 2024-2032 (USD THOUSAND)
FIGURE 24 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY CATEGORY, CAGR (2024-2032)
FIGURE 25 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY CATEGORY, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY DISEASE, 2023
FIGURE 27 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY DISEASE, 2024-2032 (USD THOUSAND)
FIGURE 28 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY DISEASE, CAGR (2024-2032)
FIGURE 29 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY DISEASE, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY ROUTE OF ADMINISTRATION, 2023
FIGURE 31 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)
FIGURE 32 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2024-2032)
FIGURE 33 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY GENDER, 2023
FIGURE 35 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY GENDER, 2024-2032 (USD THOUSAND)
FIGURE 36 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY GENDER, CAGR (2024-2032)
FIGURE 37 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY GENDER, LIFELINE CURVE
FIGURE 38 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY PATIENT TYPE, 2023
FIGURE 39 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY PATIENT TYPE, 2024-2032 (USD THOUSAND)
FIGURE 40 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY PATIENT TYPE, CAGR (2024-2032)
FIGURE 41 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 42 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY AGE GROUP, 2023
FIGURE 43 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY AGE GROUP, 2024-2032 (USD THOUSAND)
FIGURE 44 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY AGE GROUP, CAGR (2024-2032)
FIGURE 45 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 46 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 47 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)
FIGURE 48 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2032)
FIGURE 49 ASIA-PACIFIC TRAVEL VACCINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 50 ASIA-PACIFIC TRAVEL VACCINE MARKET: SNAPSHOT (2023)
FIGURE 51 ASIA-PACIFIC TRAVEL VACCINE MARKET: COMPANY SHARE 2023 (%)